Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Schmitt M et al. – Current clinical LAA peptide vaccination protocols targeting Wilms’ tumor gene, proteinase–3 and the receptor for hyaluronan–mediated motility are reviewed and an outlook to dendritic cells, adjuvants and short oligodenucleotides is given.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address